TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond
Cancer and Metastasis Reviews · 2025-03 · 44 (1)
DOI: 10.1007/s10555-024-10226-2 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer and Metastasis Reviews, online erschienen am 07.12.2024. Verfasst von Qitong Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, US…. Hauptthemen laut MEDLINE: Neoplasms, Disease Progression, Transcription Factors. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 195 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Breast Cancer Research Foundation.
Abstract (Originalsprache)
While most Tripartite motif (TRIM) family proteins are E3 ubiquitin ligases, some members have functions beyond the regulation of ubiquitination, impacting normal physiological processes and disease progression. TRIM29, an important member of the TRIM family, exerts a predominant influence on cancer growth, epithelial-to-mesenchymal transition, stemness and metastatic progression by directly potentiating multiple canonical oncogenic pathways. The cancer-promoting effect of TRIM29 is also evident in metabolic interventions and interference with the efficacy of cancer therapeutics. As expected for any key node in cancer, the expression of TRIM29 is tightly regulated by non-coding RNAs, epigenetic modulation, and post-translational regulation. A systematic discussion of how TRIM29 is regulated in cancer, its influences on cancer progression, and its impact on cancer therapeutics is presented in this review. We also explore the context-dependent alterations between TRIM29 function from oncogenic to tumor suppression. As TRIM29 is involved in multiple aspects of cancer progression, a better understanding of its biological impact in cancer may help improve prognosis and develop novel therapeutic combinations, leading to improved personalized cancer care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
- Department of Oncology, Johns Hopkins University School of Medicine and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA. dsharma7@jhmi.edu.
- Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, 1650 Orleans Street, CRB 1, Rm 145, Baltimore, MD, 21231, USA. dsharma7@jhmi.edu.
Förderung
- Breast Cancer Research Foundation
Zitieren
APA
Wu, Q., Nandi, D., & Sharma, D. (2025). TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond. Cancer and Metastasis Reviews, 44(1). https://doi.org/10.1007/s10555-024-10226-2
Vancouver
Wu Q, Nandi D, Sharma D. TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond. Cancer and Metastasis Reviews. 2025;44(1). doi:10.1007/s10555-024-10226-2
BibTeX
@article{Wu2025,
author = {Wu, Qitong and Nandi, Deeptashree and Sharma, Dipali},
title = {TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond},
journal = {Cancer and Metastasis Reviews},
year = {2025},
volume = {44},
number = {1},
doi = {10.1007/s10555-024-10226-2}
}
EUVIMED